Biofil Chemicals and Pharmaceuticals Ltd Plans Board Meeting to Review Q1 Un-Audited Financials
Biofil Chemicals & Pharmaceuticals Ltd has scheduled a meeting of its Board of Directors for Tuesday, August 11, 2026. The primary agenda item for the gathering is the consideration and approval of the Un-Audited Financial Results for the first Quarter ended on June 30, 2026.In addition to reviewing the quarterly performance data, the Board meeting is scheduled to address other routine matters as deemed necessary by the Chair.
The company also provided details regarding the opening of the trading window for its securities in continuation of earlier disclosures made on June 25, 2026. As part of the Code of Conduct regulating and monitoring insider trading, designated persons, their immediate relatives, and all connected persons are informed that the trading window for dealing in the company's securities will open after a period of 48 hours following the declaration of the Un-Audited Financial Results for the first quarter ended on June 30, 2026.
BIOFILCHEM Stock Price Movement
Shares of Biofil Chemicals & Pharmaceuticals Limited slipped by 0.78% on Friday, settling at ₹31.94 in the market session. The stock saw a trading volume of 4,753 shares during the day.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.